Bioventus Inc.BVSNASDAQ
Loading
Year-over-year free cash flow growth rate
3Y CAGR
-47.2%/yr
vs -8.4%/yr prior
Acceleration
-38.9pp
Decelerating
Percentile
P62
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 26.20% |
| Q3 2025 | 17.30% |
| Q2 2025 | 225.29% |
| Q1 2025 | -207.52% |
| Q4 2024 | 82.87% |
| Q3 2024 | -32.04% |
| Q2 2024 | 339.60% |
| Q1 2024 | -162.93% |
| Q4 2023 | 196.66% |
| Q3 2023 | -210.14% |
| Q3 2023 | 978.32% |
| Q2 2023 | -158.12% |
| Q4 2022 | 178.34% |
| Q4 2022 | -358.53% |
| Q3 2022 | 103.57% |
| Q2 2022 | -346.80% |
| Q4 2021 | 19.10% |
| Q4 2021 | -46.06% |
| Q3 2021 | 182.72% |
| Q2 2021 | -373.18% |
| Q4 2020 | -63.67% |
| Q3 2020 | 176.70% |
| Q2 2020 | -59.35% |
| Q1 2020 | -15.09% |
| Q4 2019 | 82.46% |
| Q3 2019 | 237.02% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |